Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Design and Molecular Modeling of Abiraterone-Functionalized Gold Nanoparticles.

Stolarczyk EU, Łaszcz M, Leś A, Kubiszewski M, Kuziak K, Sidoryk K, Stolarczyk K.

Nanomaterials (Basel). 2018 Aug 22;8(9). pii: E641. doi: 10.3390/nano8090641.

2.

Process-related impurities of eplerenone: determination and characterisation by HPLC methods and Raman spectroscopy.

Filip K, Łaszcz M, Leś A, Chmiel J.

J Pharm Biomed Anal. 2018 Sep 10;159:466-476. doi: 10.1016/j.jpba.2018.07.028. Epub 2018 Jul 18.

PMID:
30048894
3.

Pemetrexed conjugated with gold nanoparticles - Synthesis, characterization and a study of noncovalent interactions.

Stolarczyk EU, Stolarczyk K, Łaszcz M, Kubiszewski M, Leś A, Michalak O.

Eur J Pharm Sci. 2017 Nov 15;109:13-20. doi: 10.1016/j.ejps.2017.07.011. Epub 2017 Jul 12.

4.

Synthesis and characterization of genistein conjugated with gold nanoparticles and the study of their cytotoxic properties.

Stolarczyk EU, Stolarczyk K, Łaszcz M, Kubiszewski M, Maruszak W, Olejarz W, Bryk D.

Eur J Pharm Sci. 2017 Jan 1;96:176-185. doi: 10.1016/j.ejps.2016.09.019. Epub 2016 Sep 16.

PMID:
27644892
5.

Structural and Physicochemical Studies of Olopatadine Hydrochloride Conformational Polymorphs.

Łaszcz M, Trzcińska K, Witkowska A, Ciesielska A, Badowska-Rosłonek K, Kuziak K.

J Pharm Sci. 2016 Aug;105(8):2419-26. doi: 10.1016/j.xphs.2016.05.031. Epub 2016 Jul 1.

PMID:
27373838
6.

Studies of phase transitions in the aripiprazole solid dosage form.

Łaszcz M, Witkowska A.

J Pharm Biomed Anal. 2016 Jan 5;117:298-303. doi: 10.1016/j.jpba.2015.09.004. Epub 2015 Sep 5.

PMID:
26397209
7.

New Polymorphic Forms of Pemetrexed Diacid and Their Use for the Preparation of Pharmaceutically Pure Amorphous and Hemipentahydrate Forms of Pemetrexed Disodium.

Michalak O, Łaszcz M, Jatczak K, Witkowska A, Bujak I, Groman A, Cybulski M.

Molecules. 2015 Jul 30;20(8):13814-29. doi: 10.3390/molecules200813814.

8.

Identification and physicochemical characteristics of temozolomide process-related impurities.

Łaszcz M, Kubiszewski M, Jedynak L, Kaczmarska M, Kaczmarek Ł, Łuniewski W, Gabarski K, Witkowska A, Kuziak K, Malińska M.

Molecules. 2013 Dec 11;18(12):15344-56. doi: 10.3390/molecules181215344.

9.

Stability of sample solution as a crucial point during HPLC determination of chemical purity of temozolomide drug substance.

Jedynak Ł, Puchalska M, Zezula M, Łaszcz M, Łuniewski W, Zagrodzka J.

J Pharm Biomed Anal. 2013 Sep;83:19-27. doi: 10.1016/j.jpba.2013.04.032. Epub 2013 Apr 30.

PMID:
23702563
10.

Preparation, purification and regioselective functionalization of protoescigenin--the main aglycone of escin complex.

Gruza MM, Jatczak K, Zagrodzki B, Laszcz M, Koziak K, Malińska M, Cmoch P, Giller T, Zegrocka-Stendel O, Woźniak K, Grynkiewicz G.

Molecules. 2013 Apr 15;18(4):4389-402. doi: 10.3390/molecules18044389.

11.

Physicochemical characteristics of sunitinib malate and its process-related impurities.

Sidoryk K, Malińska M, Bańkowski K, Kubiszewski M, Łaszcz M, Bodziachowska-Panfil M, Kossykowska M, Giller T, Kutner A, Woźniak K.

J Pharm Sci. 2013 Feb;102(2):706-16. doi: 10.1002/jps.23412. Epub 2012 Dec 11.

PMID:
23233239
12.

Distinguishing between polymorphic forms of linezolid by solid-phase electronic and vibrational circular dichroism.

Frelek J, Górecki M, Laszcz M, Suszczyńska A, Vass E, Szczepek WJ.

Chem Commun (Camb). 2012 May 28;48(43):5295-7. doi: 10.1039/c2cc31207g. Epub 2012 Mar 20.

PMID:
22434149
13.

Stability studies and structural characterization of pramipexole.

Łaszcz M, Trzcińska K, Kubiszewski M, Kosmacińska B, Glice M.

J Pharm Biomed Anal. 2010 Dec 1;53(4):1033-6. doi: 10.1016/j.jpba.2010.06.018. Epub 2010 Jun 25.

PMID:
20655682
14.

Optimization of aripiprazole synthesis.

Leś A, Badowska-Rosłonek K, Łaszcz M, Kamieńska-Duda A, Baran P, Kaczmarek Ł.

Acta Pol Pharm. 2010 Mar-Apr;67(2):151-7.

Supplemental Content

Loading ...
Support Center